Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

After complete resorption, no benefit was observed with BVS compared with EES at 7-year follow-up, despite the use of a dedicated implantation protocol for BVS. In fact, after 3 years, more target lesion revascularisations occurred with BVS than with EES.

Authors

Institutions

Publication Details

Journal
EuroIntervention
Published
2026-02-01
DOI
https://doi.org/10.4244/eij-d-25-00778
Citations
1
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
39.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

Tessa Rademaker‐Havinga, Pieter C Smits, Robert-Jan van Geuns, Giuseppe Tarantini et al.
1 citations
EuroIntervention
Coronary Interventions and Diagnostics
39.15
article

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

Tessa Rademaker‐Havinga, Pieter C Smits, Robert-Jan van Geuns, Giuseppe Tarantini, Stephan Achenbach, Bernard Chevalier, Viktor Kocka, Dariusz Dudek, Tommaso Gori, Adrian Włodarczak, Jan G.P. Tijssen, Yoshinobu Onuma, Emanuele Barbato, Marie-Claude Morice, Javier Escaned, on behalf of the COMPARE-ABSORB trial investigators, Giovanni Esposito, Nick E.J. West, Patrick W. Serruys
article en
1 citations

Abstract

After complete resorption, no benefit was observed with BVS compared with EES at 7-year follow-up, despite the use of a dedicated implantation protocol for BVS. In fact, after 3 years, more target lesion revascularisations occurred with BVS than with EES.

EuroInterventionVol. 22(4)
Wrocław University of Science and Technology (PL), Jagiellonian University (PL), University of Padua (IT), Radboud University Nijmegen (NL), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Ollscoil na Gaillimhe – University of Galway (IE), Johannes Gutenberg University Mainz (DE), Charles University (CZ), Royal Papworth Hospital (GB), Radboud University Medical Center (NL), Hospital Clínico San Carlos (ES), Laboratoire Ingénierie, Procédés, Aliments (FR), University Medical Center of the Johannes Gutenberg University Mainz (DE), Maasstad Ziekenhuis (NL), Leipzig Heart Institute (DE), Federico II University Hospital (IT), Azienda Ospedaliera Sant'Andrea (IT), Institut Cardiovasculaire Paris Sud (FR), Segeberger Kliniken (DE), Hôpital Privé Jacques Cartier (FR), Amsterdam University Medical Centers (NL), Générale de Santé (FR), University Hospital Kralovske Vinohrady (CZ), Cardialysis (Netherlands) (NL), AGH University of Krakow (PL)
Good health and well-being
Openalex Percentile: Top 1%
Coronary Interventions and Diagnostics
39.15
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.